Rigel Pharmaceuticals
RIGL
#6158
Rank
โ‚ฌ0.76 B
Marketcap
42,01ย โ‚ฌ
Share price
3.25%
Change (1 day)
74.41%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): โ‚ฌ0.10 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.28 Billion. In 2024 the company made an earning of โ‚ฌ22.57 Million, an increase over its 2023 earnings that were of -โ‚ฌ15.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.10 B371.74%
2024 โ‚ฌ22.57 M-244.27%
2023 -โ‚ฌ15.65 Million-66.79%
2022 -โ‚ฌ47.12 Million340.73%
2021 -โ‚ฌ10.7 Million-56.15%
2020 -โ‚ฌ24.39 Million-57.34%
2019 -โ‚ฌ57.17 Million-7.66%
2018 -โ‚ฌ61.91 Million-9.47%
2017 -โ‚ฌ68.38 Million24.46%
2016 -โ‚ฌ54.94 Million23.63%
2015 -โ‚ฌ44.44 Million-43.29%
2014 -โ‚ฌ78.37 Million2.5%
2013 -โ‚ฌ76.46 Million
2010 โ‚ฌ32.51 M-133.97%
2009 -โ‚ฌ95.71 Million-18.49%
2008 -โ‚ฌ0.12 Billion71.91%
2007 -โ‚ฌ68.3 Million84.74%
2006 -โ‚ฌ36.97 Million-10.17%
2005 -โ‚ฌ41.16 Million-15.73%
2004 -โ‚ฌ48.84 Million39.29%
2003 -โ‚ฌ35.07 Million10.3%
2002 -โ‚ฌ31.79 Million48.3%
2001 -โ‚ฌ21.44 Million-2.13%
2000 -โ‚ฌ21.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ChemoCentryx
CCXI
-โ‚ฌ0.12 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ93.64 Million-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.24 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
โ‚ฌ7.07 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA